Next Vial review

Next Vial markets compounded NAD+ injection and nasal spray, sermorelin, glutathione and PT-141 alongside other telehealth treatments. The current public NAD+ and sermorelin selectors each include a one-month option labeled billed monthly, with no monthly membership fee. NAD+ is $199/mo in either form; sermorelin has the same printed one-month amount. Longer-plan figures are total plan offers rather than a smaller bill available month to month. Glutathione shows a starting figure without a comparable current plan schedule, so obtain its written supply and renewal terms. The NAD+ guide, nasal evidence review and sermorelin guide explain the separate clinical questions.

The FAQ names MD Integrations as the provider network and Manifest Pharmacy in Greer, South Carolina, as a pharmacy that may fill a prescription. The terms allow a requested local pharmacy, with pricing potentially different. These are disclosed relationships rather than proof of the assignment for every order. The Texas facility check below does not establish home-state or all-state licensure. The FAQ estimates clinician feedback in about 24 hours and says some states require video or live chat; that is an estimate, not a guaranteed appointment.

The GLP-1 product selector, its promotional banner and the separate weight-loss page do not present one consistent price. The latter also describes a four-week medication supply, which does not establish a four-week charge interval. Current GLP-1 comparison prices are therefore held pending a product-specific written quote. The FAQ’s state list omits Alaska and DC; confirm your location and requested therapy rather than treating a generic form option as proof of eligibility.

The FAQ says medication is billed when it ships and that the care team contacts you before a refill is billed. The returns policy allows subscription changes before shipping and makes prescription sales final after charge and carrier handoff. It promises reshipment for a lost package and asks patients to report damage. Its statement that no refrigerated products ship needs a product-specific answer from the assigned pharmacy. The terms identify Next Vial as the platform rather than the provider of the medical decision.

Product marketing also deserves scrutiny. The nasal page claims brain delivery and cognitive benefits, while the sermorelin FAQ describes a timetable for sleep, cosmetic and body-composition changes. Those descriptions do not themselves establish a clinical result, reliable timeline or superiority of one form. The sermorelin efficacy review distinguishes growth-hormone measurements from outcomes consumers may expect. Ask the clinician which evidence applies to the exact treatment and reason it is being offered.